🧬 Tau Aggregation Inhibitor Small Molecule Simulator

Small Molecule Oral Bioavailability Advantage

Small molecules offer oral dosing advantages over antibody biologics.

• Oral: Route of administration (placeholder note)
• <500 Da: Molecular weight (placeholder note)
• Favorable: BBB penetration (placeholder note)
• Daily: Dosing frequency (placeholder note)

Oral small molecule pharmacology

Placeholder: small molecule oral bioavailability and CNS penetration overview.

Blocking Tau Self-Aggregation

Inhibitor binds tau monomers to block self-aggregation.

• Repeat domain: Binding site (placeholder note)
• Aggregation block: Mechanism (placeholder note)
• Stabilized: Monomer pool (placeholder note)
• ThT fluorescence: Assay readout (placeholder note)

Tau self-aggregation blockade

Placeholder: mechanism of small molecule blocking tau monomer self-assembly.

Preventing Oligomer Formation

Inhibitor prevents formation of toxic tau oligomers.

• Reduced: Oligomer species (placeholder note)
• Lowered: Toxicity marker (placeholder note)
• Delayed: Time to oligomer (placeholder note)
• Native PAGE: Detection method (placeholder note)

Oligomer formation prevention

Placeholder: how the compound interrupts oligomer nucleation and growth.

Intracellular Target Engagement

Compound engages tau target inside neuronal cells.

• Cytosol: Cellular compartment (placeholder note)
• Confirmed: Target engagement (placeholder note)
• Neuronal line: Cell model (placeholder note)
• CETSA: Engagement assay (placeholder note)

Intracellular target engagement

Placeholder: intracellular delivery and tau target engagement details.

Combination With Antibody Approaches

Small molecule paired with anti-tau antibody for combination therapy.

• Anti-tau mAb: Combination partner (placeholder note)
• Intra + extra: Target compartments (placeholder note)
• Additive+: Expected synergy (placeholder note)
• Combo arm: Trial design (placeholder note)

Combination therapy rationale

Placeholder: rationale for combining small molecule with antibody therapy.

Placeholder: key insight on combination therapy synergy.